Navigation Links
Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
Date:7/23/2014

folio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include Roche, University of Pennsylvania, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and University of Manitoba. For more information, visit www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, including safety and efficacy for VGX-3100, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, our ability to support our broad pipeline of SynCon® active immune therapy and vaccine products, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborat
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)...   Clementia Pharmaceuticals, Inc. today announced ... part (Part B) of its natural history study ... rare, severely disabling congenital myopathy characterized by painful, ... result in the formation of new, abnormal (heterotopic) ... The multi-center, non-interventional, two-part longitudinal study is ...
(Date:5/28/2015)... 2015 MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), ... that its President and Chief Executive Officer, David ... Invitational Investor Conference being held at the Luxe ... on June 1-3, 2015. Mr. Hansen ... significant progress made in the last year and plans ...
(Date:5/28/2015)... , May 28, 2015  Caris Life Sciences®, ... promise of precision medicine, today announced the presentation ... demonstrate the utility of Caris Molecular Intelligence®, the ... mechanisms of drug resistance and pathway alterations in ... in poster sessions at the annual meeting of ...
Breaking Medicine Technology:Clementia Advances Natural History Study of Patients with Fibrodysplasia Ossificans Progressiva 2Clementia Advances Natural History Study of Patients with Fibrodysplasia Ossificans Progressiva 3MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 2MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 3MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 2Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 3Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 5
... estimate that nearly one-third of cases of melanoma ... diagnosed in women during their childbearing years. Since many women ... with the fact that melanoma is the most common form ... could be faced with developing melanoma before or during pregnancy.At ...
... Up To $55 Million in Near Term Payments ... today announced that the company has entered into ... European rights to develop and commercialize the investigational ... syndrome with constipation (IBS-C) and other gastrointestinal conditions. ...
Cached Medicine Technology:Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis 2Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis 3Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis 4Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis 5Ironwood Announces Linaclotide European Licensing Agreement with Almirall 2Ironwood Announces Linaclotide European Licensing Agreement with Almirall 3
(Date:5/28/2015)... Optimity Advisors ( Optimity ) ... of care for healthcare organizations worldwide – today ... help operationalize contracting and engagement models. As part ... series of seven “ OrangePapers” that provide ... is a strategy, operations and information technology advisory ...
(Date:5/28/2015)... what your racquet can do for you but what kind ... the launch of their new digital campaign, HEAD introduces trick ... unique skill to HEAD Pro Players and consumers around the ... demonstrates how to gain more control over the racquet and ... tennis enthusiasts everywhere to join the show. , The digital ...
(Date:5/28/2015)... 2015 Although many people have resigned ... their slow metabolism for life, never being able to ... true. There are methods to jump start the metabolism. ... low-carbohydrate, low-fat and no-fat foods, cleverly worded to lure ... times the foods contain hidden ingredients and hidden ...
(Date:5/28/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national leader ... that it will participate as an exhibitor at the ... be held June 9-14, 2015 in New Orleans, Louisiana. ... and exhibits with products and services. , Representatives ... be available to speak with attendees about its full ...
(Date:5/28/2015)... 28, 2015 JJ Mowder-Tinney, PT, PhD, NCS, ... New York Physical Therapy Association (NYPTA) by the Delegation at ... member of the NYPTA. At the National level, she ... Section Research Committee and an abstract reviewer for the Neurology ... been a member of the Program committee since 2010 and ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:Tennis Artist Baffles Novak Djokovic - HEAD Launches Trick Shot Campaign “Frame & Play” 2Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 2Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 3Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 4Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2
... 2 Responding to increased attention about clinical productivity ... Centric, Inc. ( www.usercentric.com ) - a ... a new service for the healthcare industry called ... providers. Among the technologies targeted for these service ...
... of a naturally fluorescent molecule found in all living ... according to bioengineers. , NADH, or nicotinamide adenine dinucleotide, ... for the functioning of an enzyme -- found mostly ... or mitochondria. It fuels a series of biochemical reactions ...
... Acquisition of BiotelCONSHOHOCKEN, Pa., April 2 CardioNet, Inc. ... technology company with an initial focus on the diagnosis ... into the cardiac clinical research services business and the ... The two companies entered into a binding definitive merger ...
... WASHINGTON, April 2 The following is a statement from ... (TFAH) in response to the release of the new report ... by the Robert Wood Johnson Foundation Commission to Build a ... healthy as he or she can be. And every ...
... of the Country,s Largest e-Prescribing Initiatives Drives Industry-leading Prescriber ... you recently went to your doctor and received a ... the rule. That,s right, in New Jersey more and ... pad in favor of e-prescribing technology that is improving ...
... PHILADELPHIA, April 2 John K. Davis, II has ... at the American Board of Internal Medicine (ABIM), effective ... will work closely with senior management and the Board ... operational oversight for the development and implementation of information ...
Cached Medicine News:Health News:User Centric Offers New Service, Usability Diagnostics, to Measure HIT Usability 2Health News:User Centric Offers New Service, Usability Diagnostics, to Measure HIT Usability 3Health News:Naturally fluorescent molecules may serve as cancer biomarker 2Health News:Naturally fluorescent molecules may serve as cancer biomarker 3Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 2Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 3Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 4Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 5Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 6Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 2Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 3Health News:Horizon Blue Cross Blue Shield of New Jersey and CVS Caremark Reach 5.5 Million e-Prescriptions 2Health News:Horizon Blue Cross Blue Shield of New Jersey and CVS Caremark Reach 5.5 Million e-Prescriptions 3Health News:Horizon Blue Cross Blue Shield of New Jersey and CVS Caremark Reach 5.5 Million e-Prescriptions 4Health News:John K. Davis, II to Join the American Board of Internal Medicine as Chief Information Officer 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: